Implantable intraocular drug delivery apparatus, system and method

Abstract

The present invention relates to an apparatus, system and method for, and for providing, intraocular delivery of an active agent. The apparatus, system and method may include an implantable scaffold and an active agent associated with the implantable scaffold. The implantable scaffold and the active agent may be configured to be completely contained within the eye upon implantation. The implantable scaffold may be a mechanical scaffold, or the implantable scaffold may be a chemical scaffold.

1 .- 29 . (canceled) 
     
     
         30 . A method of providing intraocular delivery of an active agent in an eye, comprising:
 providing an implantable mechanical scaffold, wherein the implantable mechanical scaffold comprises an interior reservoir and is formed from a flexible material, wherein the implantable mechanical scaffold is in the shape of a cylinder;   associating the active agent with the implantable mechanical scaffold;   performing an intraocular implantation of the implantable mechanical scaffold and the active agent;   positioning an external reservoir configured to be positioned outside of the eye when the implantable mechanical scaffold is intraocularly implanted, wherein the external reservoir is separate from the implantable mechanical scaffold and comprises an injection port;   fluidly connecting the external reservoir to the interior reservoir via a tube;   delivering the active agent from the scaffold following the intraocular implantation; and   refilling the interior reservoir with the active agent via the injection port of the external reservoir after the intraocular implantation.   
     
     
         31 . The method of  claim 30 , wherein associating the active agent with the implantable mechanical scaffold comprises filling at least a portion of the mechanical scaffold with the active agent. 
     
     
         32 . The method of  claim 31 , wherein delivering the active agent includes at least release of the active agent from the filled portion of the implantable mechanical scaffold. 
     
     
         33 . The method of  claim 30 , wherein the implantable mechanical scaffold comprises a chemical scaffold. 
     
     
         34 . The method of  claim 30 , wherein the interior reservoir contains at least a portion of the active agent. 
     
     
         35 . The method of  claim 34 , wherein the interior reservoir releases at least a portion of the active agent in response to a condition within the eye. 
     
     
         36 . The method of  claim 30 , wherein the implantable mechanical scaffold comprises a coating comprising at least a portion of the active agent. 
     
     
         37 . The method of  claim 36 , further comprising releasing the active agent from the coating over time. 
     
     
         38 . The method of  claim 30 , wherein the active agent is delivered over a period of at least 6 months. 
     
     
         39 . The method of  claim 30 , wherein the active agent is delivered over a period of at least 1 year. 
     
     
         40 . The method of  claim 33 , wherein the chemical scaffold comprises a polymeric gel. 
     
     
         41 . The method of  claim 40 , wherein the polymeric gel comprises a polysaccharide. 
     
     
         42 . The method of  claim 41 , wherein the polysaccharide has an average molecular weight of 700 kDa or greater. 
     
     
         43 . The method of  claim 41 , wherein the polysaccharide has an average molecular weight of 1000 kDa or greater. 
     
     
         44 . The method of  claim 41 , wherein at least two polysaccharides are crosslinked through carboxylic acid groups. 
     
     
         45 . The method of  claim 41 , wherein at least two polysaccharides are crosslinked through hydroxyl groups. 
     
     
         46 . The method of  claim 40 , wherein the active agent is released from the polymeric gel upon degradation of the polymeric gel. 
     
     
         47 . The method of  claim 33 , wherein the active agent is connected to the chemical scaffold by covalent bonding. 
     
     
         48 . The method of  claim 33 , wherein the active agent is ionically coupled to the chemical scaffold. 
     
     
         49 . The method of  claim 30 , wherein the flexible material is a polymer. 
     
     
         50 . The method of  claim 49 , wherein the polymer is selected from one or more of a polyimide, polyvinylidene fluoride, silicone, polytetrafluoroethylene, expanded polytetrafluoroethylene, differential fluoropolymer, fluorinated ethylene propylene, prolene/polyolefins, polypropylene, poly(methyl methacrylate), acrylic, polyethylene terephthalate, polyethylene, polylactide, parylene, nylon (polyamide), polyether ether ketone, polysulfone, polyamideimides, polyether block amides, polyurethanes, thermoplastic elastomers, and liquid crystal polymers. 
     
     
         51 . The method of  claim 30 , wherein the flexible material is a metal. 
     
     
         52 . The method of  claim 51 , wherein the metal can be selected from a list including nitinol, platinum, stainless steel, molybdenum, gold, and combinations thereof. 
     
     
         53 . The method of  claim 30 , wherein the flexible material is a combination of metal and polymer.